EE9900206A - N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid - Google Patents

N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid

Info

Publication number: EE9900206A
Authority: EE; Estonia
Prior art keywords: pharmaceutical compositions; compositions containing; sulfonylindoline; derivatives; sulfonylindoline derivatives
Prior art date: 1996-12-05

Application number

EEP199900206A

Other languages

English (en)

Estonian (et)

Inventor

John Fuller Simon

Gautier Jean-Claude

Original Assignee

Sanofi

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-05

Filing date

1997-12-04

Publication date

1999-12-15

1997-12-04 Application filed by Sanofi filed Critical Sanofi

1999-12-15 Publication of EE9900206A publication Critical patent/EE9900206A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

EEP199900206A 1996-12-05 1997-12-04 N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid EE9900206A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9614957A FR2756736B1 (fr)	1996-12-05	1996-12-05	Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
PCT/FR1997/002210 WO1998024430A1 (fr)	1996-12-05	1997-12-04	Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Publications (1)

Publication Number	Publication Date
EE9900206A true EE9900206A (et)	1999-12-15

Family

ID=9498376

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP199900206A EE9900206A (et)	1996-12-05	1997-12-04	N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid

Country Status (25)

Country	Link
EP (1)	EP0941090A1 (is)
JP (1)	JP2000507618A (is)
KR (1)	KR20000069308A (is)
CN (1)	CN1239887A (is)
AR (1)	AR009651A1 (is)
AU (1)	AU716575B2 (is)
BR (1)	BR9712406A (is)
CA (1)	CA2273990A1 (is)
CO (1)	CO4910129A1 (is)
DZ (1)	DZ2362A1 (is)
EE (1)	EE9900206A (is)
FR (1)	FR2756736B1 (is)
HU (1)	HUP0001386A3 (is)
ID (1)	ID23373A (is)
IL (1)	IL129936A0 (is)
IS (1)	IS5062A (is)
MY (1)	MY132819A (is)
NO (1)	NO992724D0 (is)
NZ (1)	NZ335750A (is)
RU (1)	RU2174394C2 (is)
SK (1)	SK75599A3 (is)
TR (1)	TR199901702T2 (is)
WO (1)	WO1998024430A1 (is)
YU (1)	YU23099A (is)
ZA (1)	ZA9710919B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2786486B3 (fr) *	1998-11-16	2000-12-08	Sanofi Sa	Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
DE19913692A1 (de) *	1999-03-25	2000-09-28	Basf Ag	Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
US6437006B1 (en)	1999-09-27	2002-08-20	American Cyanamid Company	Pharmaceutical carrier formulation
DE60028754T2 (de)	1999-11-12	2007-05-31	Abbott Laboratories, Abbott Park	Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
US7364752B1 (en)	1999-11-12	2008-04-29	Abbott Laboratories	Solid dispersion pharamaceutical formulations
FR2805992A1 (fr) *	2000-03-08	2001-09-14	Sanofi Synthelabo	Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
DE10026698A1 (de)	2000-05-30	2001-12-06	Basf Ag	Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
ITMI20011338A1 (it) *	2001-06-26	2002-12-26	Farmatron Ltd	Composizioni farmaceutiche orali a rilascio immediato del principio attivo
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
UA119324C2 (uk) *	2013-04-02	2019-06-10	Теміс Медікер Лімітед	Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
KR102139339B1 (ko) *	2013-06-24	2020-07-29	주식회사 엘지생활건강	인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물
KR102139338B1 (ko) *	2013-06-24	2020-07-29	주식회사 엘지생활건강	인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3237814A1 (de) *	1982-10-12	1984-04-12	Warner-Lambert Co., 07950 Morris Plains, N.J.	Wasserfreie emulsionen und verwendung derselben
FR2679903B1 (fr) *	1991-08-02	1993-12-03	Elf Sanofi	Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

1996
- 1996-12-05 FR FR9614957A patent/FR2756736B1/fr not_active Expired - Fee Related
1997
- 1997-12-03 DZ DZ970212A patent/DZ2362A1/xx active
- 1997-12-04 ZA ZA9710919A patent/ZA9710919B/xx unknown
- 1997-12-04 BR BR9712406-0A patent/BR9712406A/pt unknown
- 1997-12-04 ID IDW990445D patent/ID23373A/id unknown
- 1997-12-04 TR TR1999/01702T patent/TR199901702T2/xx unknown
- 1997-12-04 CO CO97071118A patent/CO4910129A1/es unknown
- 1997-12-04 EE EEP199900206A patent/EE9900206A/xx unknown
- 1997-12-04 CN CN97180304A patent/CN1239887A/zh active Pending
- 1997-12-04 NZ NZ335750A patent/NZ335750A/en unknown
- 1997-12-04 SK SK755-99A patent/SK75599A3/sk unknown
- 1997-12-04 WO PCT/FR1997/002210 patent/WO1998024430A1/fr not_active Ceased
- 1997-12-04 MY MYPI97005848A patent/MY132819A/en unknown
- 1997-12-04 EP EP97950228A patent/EP0941090A1/fr not_active Withdrawn
- 1997-12-04 IL IL12993697A patent/IL129936A0/xx unknown
- 1997-12-04 KR KR1019997004983A patent/KR20000069308A/ko not_active Ceased
- 1997-12-04 RU RU99114019/14A patent/RU2174394C2/ru active
- 1997-12-04 AU AU53262/98A patent/AU716575B2/en not_active Ceased
- 1997-12-04 AR ARP970105696A patent/AR009651A1/es unknown
- 1997-12-04 JP JP10525294A patent/JP2000507618A/ja active Pending
- 1997-12-04 HU HU0001386A patent/HUP0001386A3/hu unknown
- 1997-12-04 CA CA002273990A patent/CA2273990A1/fr not_active Abandoned
1999
- 1999-05-26 YU YU23099A patent/YU23099A/sr unknown
- 1999-06-01 IS IS5062A patent/IS5062A/is unknown
- 1999-06-04 NO NO992724A patent/NO992724D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL129936A0 (en)	2000-02-29
ID23373A (id)	2000-04-20
YU23099A (en)	1999-11-22
EP0941090A1 (fr)	1999-09-15
FR2756736B1 (fr)	1999-03-05
ZA9710919B (en)	1999-06-04
FR2756736A1 (fr)	1998-06-12
MY132819A (en)	2007-10-31
KR20000069308A (ko)	2000-11-25
DZ2362A1 (fr)	2002-12-28
IS5062A (is)	1999-06-01
BR9712406A (pt)	1999-08-31
TR199901702T2 (en)	1999-09-21
NO992724L (no)	1999-06-04
SK75599A3 (en)	2000-08-14
AU716575B2 (en)	2000-03-02
WO1998024430A1 (fr)	1998-06-11
HUP0001386A2 (hu)	2001-04-28
AR009651A1 (es)	2000-04-26
CO4910129A1 (es)	2000-04-24
CA2273990A1 (fr)	1998-06-11
NZ335750A (en)	2001-06-29
HUP0001386A3 (en)	2002-03-28
CN1239887A (zh)	1999-12-29
RU2174394C2 (ru)	2001-10-10
NO992724D0 (no)	1999-06-04
AU5326298A (en)	1998-06-29
JP2000507618A (ja)	2000-06-20

Publication	Publication Date	Title
FI20071025L (fi)	2007-12-28	Farmaseuttisia koostumuksia
CY2005007I2 (el)	2009-11-04	Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
IS4706A (is)	1998-03-31	Lyfjasamsetningar
ID18352A (id)	1998-04-02	Komposisi-komposisi farmasi
DK0938345T3 (da)	2004-01-12	Vandbaseret farmaceutisk sammensætning
ID22891A (id)	1999-12-16	Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
EE03852B1 (et)	2002-10-15	Bensofuraani derivaate sisaldav tahke farmatseutiline kompositsioon
FI991302L (fi)	1999-06-08	Parannetut farmaseuttiset koostumukset
EE9900206A (et)	1999-12-15	N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
BR9507768A (pt)	1997-09-02	Composição farmacêutica
EE9800400A (et)	1999-06-15	Diklofenaaki sisaldavad farmatseutilised kompositsioonid
PT969815E (pt)	2005-07-29	Composicoes farmaceuticas
PT941100E (pt)	2003-10-31	Composicoes farmaceuticas
ITMI942166A0 (it)	1994-10-21	Composizioni farmaceutiche miorilassanti
EE200000330A (et)	2001-08-15	Farmatseutilised kompositsioonid
FI973280A0 (fi)	1997-08-08	Farmaseuttinen koostumus
FI961364L (fi)	1997-09-26	Lääkeainekoostumus
ITMI962628A0 (it)	1996-12-16	Composizione farmaceutica
BR9605777A (pt)	1998-08-25	Composição farmacêutica
FI954050L (fi)	1996-03-02	Lääkekoostumuksia
FI962738A0 (fi)	1996-07-03	Farmaseuttiset koostumukset
NO994436D0 (no)	1999-09-13	Farmasöytiske sammensetninger
BR9605131A (pt)	1998-07-07	Composição farmacêutica
IT1272935B (it)	1997-07-01	Composizione farmaceutica contenente n-acetil-cisteina
SE9604299D0 (sv)	1996-11-22	Pharmaceutical composition